Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2014 - 2024)
Scinai Immunotherapeutics (SCNI) posted Interest Coverage Ratio of 1.65 for Q4 2024, down 112.22% sequentially from 13.48 in Q1 2024, and up 90.24% YoY from 0.87 in Q1 2024.
Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2014 - 2024) Analysis & Trends
Scinai Immunotherapeutics has reported Interest Coverage Ratio for 11 years, with the latest figure at 1.65 in Q4 2024.
- Quarterly Interest Coverage Ratio rose 90.24% year-over-year to 1.65 in Q4 2024, while the trailing twelve-month figure through Mar 2026 was 6.19 (up 30.01% YoY) and the FY2025 annual result came in at 0.34, up 6.24% from the prior year.
- Interest Coverage Ratio retreated to 1.65 in Q4 2024 per SCNI's latest filing, from 13.48 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 135.47 in Q1 2020 and troughed at 193.07 in Q3 2020.
- A 5-year average of 1.46 and a median of 2.73 in 2023 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 3724.82% in 2020, down 713.18% in 2020.
- Over 5 years, Interest Coverage Ratio stood at 20.81 in 2020, then tumbled by 92.76% to 1.51 in 2021, then tumbled by 467.21% to 5.54 in 2022, then tumbled by 204.89% to 16.88 in 2023, then jumped by 90.24% to 1.65 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.65, 13.48, and 16.88 for Q4 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Scinai Immunotherapeutics | 11.78 Mn | -3.10 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.65 |
| Mar 31, 2024 | 13.48 |
| Dec 31, 2023 | -16.88 |
| Sep 30, 2023 | 2.73 |
| Jun 30, 2023 | 3.37 |
| Mar 31, 2023 | 4.39 |
| Dec 31, 2022 | -5.54 |
| Sep 30, 2022 | -0.42 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | 3.55 |
| Dec 31, 2021 | 1.51 |
| Sep 30, 2021 | 2.94 |
| Jun 30, 2021 | 2.88 |
| Mar 31, 2021 | 2.58 |
| Dec 31, 2020 | 20.81 |
| Sep 30, 2020 | -193.07 |
| Mar 31, 2020 | 135.47 |
| Sep 30, 2019 | 31.49 |
| Jun 30, 2019 | 0.10 |
| Mar 31, 2019 | 3.54 |